MedPath

Automated speech analysis in psychosis

Conditions
psychosis
schizophrenia
10039628
Registration Number
NL-OMON51301
Lead Sponsor
psychiatrie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

1. All participants must give signed informed consent;
2. Participants have a psychotic disorder classified according to DSM-5;
3. Participants are 16-46 years

Exclusion Criteria

1. Unable to give informed consent to all aspects of the study;
2. Unable to speak and be interviewed in Dutch;
3. Neurological comorbidities affecting speech, e.g. brain haemorrhage.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Automatic quantified acoustic aspects of speech (e.g duration of pauses,<br /><br>changes in pitch and mean sentence lengths) and complex tests scores at the<br /><br>different linguistic levels phonology, semantics and syntax selected for<br /><br>language production and comprehension. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>We will relate speech characteristics and test scores from the DIMA to the<br /><br>severity of positive, negative and cognitive psychosis symptoms. </p><br>
© Copyright 2025. All Rights Reserved by MedPath